Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
79,719,412
-
Total 13F shares
-
20,299,967
-
Share change
-
+547,673
-
Total reported value
-
$1,247,002,136
-
Price per share
-
$62.00
-
Number of holders
-
74
-
Value change
-
+$53,009,741
-
Number of buys
-
47
-
Number of sells
-
29
Institutional Holders of Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) as of Q4 2020
As of 31 Dec 2020,
Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,299,967 shares.
The largest 10 holders included
Redmile Group, LLC, BVF INC/IL, FMR LLC, BAKER BROS. ADVISORS LP, Deer IX & Co. Ltd., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Rock Springs Capital Management LP, AJU IB Investment Co., Ltd., and VANGUARD GROUP INC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.